Large gap with delayed quotes
|
Last quote
04/25/2026
-
02:00:00
|
Bid
04/27/2026 -
14:31:03
|
Bid Volume |
Ask
04/27/2026 -
14:31:03
|
Ask Volume |
|---|---|---|---|---|
|
52.72
-0.11
(
-0.21% )
|
52.17
|
200 |
57.61
|
100 |
Analysis date: 24.04.2026
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 06.01.2026.
Interest
Strong
Strong
Three stars since 03.04.2026.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 06.01.2026 at a price of 46.14.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 03.04.2026.
4wk Rel Perf
58.94%
58.94%
The four-week dividend-adjusted overperformance versus SP500 is 58.94%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 15.07.2025.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 5.50%.
Mkt Cap in $bn
2.72
2.72
With a market capitalization between $2 & $8bn, SOLENO THERAPEUTICS is considered a mid-cap stock.
G/PE Ratio
1.69
1.69
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
6.14
6.14
The estimated PE is for the year 2028.
LT Growth
10.37%
10.37%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
9
9
Over the last seven weeks, an average of 9 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
116
116
For 1% of index variation, the stock varies on average by 1.16%.
Correlation
0.21
0.21
Stock movements are strongly independent of index variations.
Value at Risk
40.94
40.94
The value at risk is estimated at USD 40.94. The risk is therefore 77.65%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
15.07.2025
15.07.2025